Health Advocacy, Inc.
How Pharmaceutical Funding Changed the Breast Cancer Movement
- PUBLISHED: September 2019
- SUBJECT LISTING: Women’s, Gender, and Sexuality Studies, Health
- BIBLIOGRAPHIC INFORMATION: 288 Pages, 6 x 9 in
- ISBN: 9780774833851
Over the past several decades, a gradual reduction in state funding has pressured patient groups into forming private-sector partnerships. Health activist, scholar, award-winning journalist, and cancer survivor Sharon Batt investigates the relationship between patient advocacy groups and the pharmaceutical industry, as well as the contentious role of pharma funding. This analysis of Canada’s breast cancer movement from 1990 to 2010 argues that the resulting power imbalance undermined the groups’ ability to put patients’ interests ahead of those of the funders. A movement that once encouraged democratic participation in the development of health policy now eerily echoes the demands of the pharmaceutical industry.
Authors & Contributors
Sharon Batt is an independent scholar and adjunct professor in the Department of Bioethics at Dalhousie University.
Batt’s analysis of the changes in governmental priorities, drug costs, and patients’ expectations clearly has applicability all around the globe. . . . It should be devoured by anyone, from any nation, who wants to put together a similarly formidable argument for transparent and genuine discussion about what we should – indeed, must – do differently to prevent and treat human suffering and disease.- Nancy MP King, Indian Journal of Medical Ethics